NCT03785977 is a clinical trial in Airway Deadspace, sponsored by Wake Forest University Health Sciences.

Who is sponsoring NCT03785977?

NCT03785977 is sponsored by Wake Forest University Health Sciences.

What condition does NCT03785977 study?

NCT03785977 studies Airway Deadspace.

Is NCT03785977 still recruiting?

NCT03785977 is currently completed. Last updated 27 March 2020.

Last reviewed 2020-03-27 · How we verify

NCT03785977

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Airway Deadspace in Children: Air-Q Versus Endotracheal Tube

Completed Last updated 27 March 2020

What this trial tests

trial in Airway Deadspace in 62 participants. Completed in 9 August 2019.

Timeline

25 March 2019

Primary endpoint
9 August 2019

9 August 2019

Quick facts

Lead sponsor	Wake Forest University Health Sciences
Status	Completed
Study type	OBSERVATIONAL
Enrollment	62
Start date	25 March 2019
Primary completion	9 August 2019
Estimated completion	9 August 2019
Sites	1 location across United States

Conditions studied

Airway Deadspace — all drugs for Airway Deadspace →

Sponsor

Wake Forest University Health Sciences

Who can join

Adults 3 Months to 6, any sex, with Airway Deadspace. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study will be to measure the airway deadspace associated with use of appropriately sized an AirQ, a commonly used supraglottic airway in young children weighing between 5 and 20 kg and compare that to the airway deadspace associated with use of an endotracheal tube (ETT) in similarly sized children undergoing controlled ventilation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A comparison of the breathing apparatus deadspace associated with a supraglottic airway and endotracheal tube using volumetric capnography in young children.
Goenaga-Diaz EJ, Smith LD, Pecorella SH, Smith TE, et al · · 2021 · cited 1× · PMID 33198431 · DOI 10.4097/kja.20518

Verify or expand the search:

Other Wake Forest University Health Sciences trials

Trials by the same sponsor.

NCT07474090 — Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial · NA · not yet recruiting
NCT07282444 — A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial · NA · not yet recruiting
NCT06876896 — Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter · NA · recruiting
NCT07227051 — Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity · NA · recruiting
NCT07215624 — Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03785977 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wake Forest University Health Sciences
Last refreshed: 27 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03785977.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing